TWST Form 4: COO Patrick Finn reports 79,785-share PSU award
Rhea-AI Filing Summary
Twist Bioscience (TWST): insider equity award update. President and COO Patrick John Finn acquired 79,785 shares of common stock at $0 on October 28, 2025, recorded as an “A” (acquisition). Following this transaction, he beneficially owns 286,280 shares directly. The shares reflect Performance Stock Units for which target criteria were determined to have been met on October 28, 2025. According to the award terms, 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration as provided in the award agreement.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: PSU milestone met; partial vesting scheduled.
Patrick John Finn, President and COO of Twist Bioscience, reported an acquisition of 79,785 common shares at
The filing notes that
Future share delivery depends on service conditions and any acceleration provisions in the award. Actual impact on share count depends on the vesting and settlement of remaining PSUs per the stated schedule.